Dr. Sumner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N. Wolfe Street
Rangos, Room 248
Baltimore, MD 21287Phone+1 410-614-0093Fax+1 410-502-5459
Summary
- I am a board certified neurologist who specializes in neuromuscular disorders. Areas of particular expertise include inherited peripheral nerve, motor neuron, and muscle diseases such as Charcot Marie Tooth disease, spinal muscular atrophy, and muscular dystrophy.
Education & Training
- University of California (San Francisco)Residency, Neurology, 1997 - 2000
- Perelman School of Medicine at the University of PennsylvaniaClass of 1996
Certifications & Licensure
- CA State Medical License 1998 - Present
- MD State Medical License 2007 - 2025
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Publications & Presentations
PubMed
- Onasemnogene-abeparvovec administration to premature infants with spinal muscular atrophy.Stephen M Brown, Aparna S Ajjarapu, Divya Ramachandra, Laura Blasco-Pérez, Mar Costa-Roger
Annals of Clinical and Translational Neurology. 2024-11-01 - The expanding application of antisense oligonucleotides to neurodegenerative diseases.Charlotte J Sumner, Timothy M Miller
The Journal of Clinical Investigation. 2024-10-01 - A reassessment of spinal cord pathology in severe infantile spinal muscular atrophy: Reassessment of spinal cord pathology.Hazel Allardyce, Benjamin D Lawrence, Thomas O Crawford, Charlotte J Sumner, Simon H Parson
Neuropathology and Applied Neurobiology. 2024-10-01
Press Mentions
- 2022 Cure SMA Annual Research Meeting Summaries – Special and Clinical Research SessionAugust 15th, 2022
- News from the AAN Annual Meeting: In Phase 3 Results, Infants on Nusinersen Survive Longer, Achieve Motor MilestonesMay 18th, 2017
- SMA Infants Do Better with NusinersenApril 25th, 2017
- Join now to see all
Grant Support
- Muscle And Neuromuscular Junctions In Spinal Muscular AtrophyNational Institute Of Neurological Disorders And Stroke2009–2012
- Regulation Of The Survival Motor Neuron GeneNational Institute Of Neurological Disorders And Stroke2006–2008
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/charlotte-sumner
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: